Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. (AMRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
amrx · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$19.00
Consensus
$17.33
+25.6% upside
Low
$16.00
Median: $17 · Last Close: $13.79
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$17.33
25.6% upside
High Target
$19
37.7%
Low Target
$16
16.0%
Current Price
$13.79
as of today
Based on analyst price targets, the AMRX stock price prediction for the next 12 months ranges from $16 to $19. The consensus AMRX price forecast of $17.33 implies 25.6% upside from the current price of $13.79.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.22 | ↑ 3.08% |
1-day model range: $14.17–$14.27. Peak: $14.27 (+3.08%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | +60.1% |
| 2028 | $30 | +117.7% |
| 2029 | $37 | +164.8% |
| 2030 | $41 | +199.1% |
| 2031 | — | +222.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AMRX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Barclays | Maintains | Overweight→Overweight |
| 2026-03-02 | Truist Securities | Maintains | Buy→Buy |
| 2025-10-31 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-09-16 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-03-03 | Barclays | Maintains | Overweight→Overweight |
| 2025-02-24 | JP Morgan | Upgrade ↑ | Neutral→Overweight |
| 2024-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-10-02 | Truist Securities | Maintains | Buy→Buy |
| 2024-09-06 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2024-08-13 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Amneal Pharmaceuticals, Inc. (AMRX) stock. Of the recent 67 rating actions, 10 were upgrades and 7 were downgrades. 16 analysts currently cover AMRX.
Analyst Recommendation Trends
AMRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.8B
↓ 10.7% YoY
Revenue Next Year
$3.0B
↑ 8.7% YoY
EPS This Year
$0.61
EPS Next Year
$0.80
↑ 30.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast AMRX EPS of $0.61 for the current fiscal year, based on estimates from 3 analysts. The AMRX revenue forecast is $2.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AMRX stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AMRX price target is $17.33 (+25.6% upside), with an analyst consensus of Buy.
The AMRX short-term stock prediction for tomorrow is $14.22 (+3.08%). The AMRX stock price prediction for 2027 estimates an average of $22. The AMRX stock prediction for 2030 projects a range of $40–$43.
Amneal Pharmaceuticals, Inc. trades on NASDAQ under the ticker AMRX. The AMRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 63% of covering analysts.
Frequently asked questions
AMRX forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month AMRX price target is $17.33, with a high forecast of $19.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies +25.6% potential upside from the current price of $13.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.